GlucoTrack, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GCTK research report →
Companywww.glucotrack.com
GlucoTrack, Inc. , a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
- CEO
- Paul V. Goode
- IPO
- 2013
- Employees
- 11
- HQ
- Or Yehuda, IL
Price Chart
Valuation
- Market Cap
- $268.58K
- P/E
- -0.09
- P/S
- 0.00
- P/B
- -0.91
- EV/EBITDA
- 0.22
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -283.29%
- ROIC
- 1378.92%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-19,388,000 · 14.20%
- EPS
- $-21.56 · -135.48%
- Op Income
- $-16,090,000
- FCF YoY
- -21.77%
Performance & Tape
- 52W High
- $15.90
- 52W Low
- $0.43
- 50D MA
- $0.86
- 200D MA
- $3.86
- Beta
- 0.72
- Avg Volume
- 4.76M
Get TickerSpark's AI analysis on GCTK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 25 | CARR BRENDEL VICTORIA | other | 0 |
| Oct 3, 25 | Balo Andrew K | other | 1,285 |
| Oct 3, 25 | Balo Andrew K | other | 4,055 |
| Jul 11, 25 | Balo Andrew K | other | 3,332 |
| Mar 25, 25 | Balo Andrew K | other | 75 |
| Oct 3, 25 | Malave Luis | other | 463 |
| Oct 3, 25 | Malave Luis | other | 4,055 |
| Jul 11, 25 | Malave Luis | other | 1,200 |
| Mar 25, 25 | Malave Luis | other | 35 |
| Oct 3, 25 | Carter Erin Catherine | other | 4,055 |
Our GCTK Coverage
We haven't published any research on GCTK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GCTK Report →